SGLT-2 INHIBITOR FOR TREATING TYPE 1 DIABETES MELLITUS, TYPE 2 DIABETES MELLITUS, IMPAIRED GLUCOSE TOLERANCE OR HYPERGLYCEMIA III SGLT-2 von EICKELMANN, PETER P, SEMAN, LEO JOHN LJ, GREMPLER, ROLF R, MARK, MICHAEL M, THOMAS, LEO L, BROEDL, ULI U

Volltext bestellen

PHARMACEUTICAL COMPOSITION COMPRISING A SGLT2 INHIBITOR, A DPP-IV INHIBITOR AND OPTIONALLY A FURTHER ANTIDIABETIC AGENT AND USES THEREOF SGLT2 DPP-IV von SEMAN, Leo John LJ, BROEDL, Uli U, EICKELMANN, Peter P, THOMAS, Leo L, GREMPLER, Rolf R, MARK, Michael M

Volltext bestellen

An intercomparison of cloud‐resolving models with the atmospheric radiation measurement summer 1997 intensive observation period data von Xu, Kuan‐Man, Cederwall, Richard T., Donner, Leo J., Grabowski, Wojciech W., Guichard, Françoise, Johnson, Daniel E., Khairoutdinov, Marat, Krueger, Steven K., Petch, Jon C., Randall, David A., Seman, Charles J., Tao, Wei‐Kuo, Wang, Donghai, Cheng Xie, Shao, Yio, J. John, Zhang, Ming‐Hua

Volltext

The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings von Jenner, Jennifer L., Seman, Leo J., Millar, John S., Lamon-Fava, Stefania, Welty, Francine K., Dolnikowski, Gregory G., Marcovina, Santica M., Lichtenstein, Alice H., Barrett, P. Hugh R., deLuca, Carl, Schaefer, Ernst J.

Volltext